Founded with a mission to revolutionize metabolic health monitoring, Metre focuses on providing noninvasive, cost-effective solutions. Their flagship product, MetreAce, is a breath acetone measurement device that offers the precision of blood BHB ketone tests without the invasiveness or high costs. Paired with an iOS app for seamless user experience, MetreAce aims to deliver accurate metabolic health insights to a broad market, including individuals managing their diet, fitness enthusiasts, and those monitoring metabolic conditions.
Metre has garnered attention for its innovative approach and scientifically validated technology. The team behind Metre includes experts in metabolic health and technology, ensuring the product's reliability and effectiveness. Notable investors and affiliations have supported the company's growth, contributing to its credibility in the health tech industry. MetreAce's impact is evidenced by its adoption among users seeking precise and convenient metabolic health monitoring, setting a new standard in noninvasive health diagnostics.
